Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available)

Product description

Voriconazole 200 mg/Vial Powder for Solution for Infusion
Reference Product: Vfend® / Pfizer
Description: In the treatment of the following fungal infections: Invasive aspergillosis, Candidemia, Esophageal candidiasis, Serious fungal infections caused by Scedosporium apiospermum (asexual form of Pseudallescheria boydii) and Fusarium spp. including Fusarium solani, in patients intolerant of, or refractory to, other therapy.
Dossier Status: EU CTD Available
Stability Studies: Zone II / Zone IVb
Shelf life: Three (3) years
Batch Sizes: 12,000 vials
Pack Sizes: BT x 1 vial
Read more

Specifications

Categories Generic APIsGeneric Antibiotics; Finished Dosage FormsInjectables; Contract Services - Contract ServicesLyophilisation
Sales markets Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia)
Supplied from Greece
Selling Points International Approvals/Standards

More products from ANFARM HELLAS S.A.

View all our products (37)
Voriconazole Pd.Sol.Inf 200mg/Vial (EU CTD Available)

Contact information

Address

Telephone

Website

View all contact information
Curia - From Curiosity to Cure

Curia - From Curiosity to Cure

Datwyler Pharma Packaging

Datwyler Pharma Packaging

Alfasigma  Contract Manufacturing Showroom

Alfasigma Contract Manufacturing Showroom

CONTENT GROUP

CONTENT GROUP

Lonza

Lonza